Friendly reminder that many members of the #disability community members prefer #IdentityFirst language (e.g. disabled person) over #PersonFirst language (e.g. person with disability). Which to use depends on a few factors. 1/2
🧠🇨🇦 After battling autoimmune encephalitis / #AE, Alanna transformed her journey into advocacy. From patient to research partner - her story inspires change.
Read more: sumairafoundation.org/alanna…
The CONSORT–Children and Adolescents (CONSORT-C) 2026 guideline extends CONSORT 2025 with 13 new reporting items for pediatric RCTs, enhancing transparency, reproducibility, and relevance for patients aged 0 to 19 years.
ja.ma/4ax2T67
SickKids-led papers co-published in BMJ, JAMA and Lancet journals introduce 30 new protocols and reporting items for paediatric randomized controlled trials, co-developed with youth and family caregivers.
Read the #SKResearch ⬇️
sickkids.ca/en/news/archive/…
We are proud to share that three #DLSPH PhD students were selected as Connaught Fellows this year.
These students will lead projects to enhance the care of those who have disabilities or diseases.
🔗 Read about their projects: ow.ly/3iMn50XNcKu.
@ihpmeuoft#Innovation
📣 Peel residents! Help shape the future of your community by taking the Peel Community Flourishing Survey. Your input on health, social, and environmental factors is vital! 📝🌟
👉 Complete the survey rebrand.ly/flourish2#PeelRegion#Survey#CommunityFlourishing#Health
Free registration is open for Neurovascular Family Education Day 2025!
Connect with parents, caregivers and patients & learn more about pediatric neurovascular malformations, available treatment options & ongoing research.
📅 Oct. 25
📍 Hybrid
👉 web.cvent.com/event/0ffb9b42…
📢 New paper alert! The TIDieR-C guideline presents 13 pediatric considerations to support transparent reporting of trial interventions in pediatric trial protocols & reports.
Paper ➡️ tinyurl.com/ymbves7p
Fillable checklists ➡️ tinyurl.com/56nfj25p
📢 New paper alert! The TIDieR-C guideline presents 13 pediatric considerations to support transparent reporting of trial interventions in pediatric trial protocols & reports.
Paper ➡️ tinyurl.com/ymbves7p
Fillable checklists ➡️ tinyurl.com/56nfj25p
Check out our Special report “Exploring the Ethical Landscape of Pediatric Neuroendovascular Treatments” A topical and important discussion!
@SickKidsNews@SickKidsNV@PMuthusami
The August 2025 issue of #Stroke is now available. Check out the issue for the latest Original Contributions, as well as Topical Reviews, Special Reports, Comments and Opinions, and more. #AHAJournalsahajrnls.org/44PiESW
CORD applauds BC’s Health Ministry for reinstating access to Charleigh’s medication putting the expertise of her physician and family first. This is true patient-centred care, backed by evidence and compassion. cheknews.ca/breaking-charlei…
Canada needs a Minister with Research in their title.
Sectors like aviation, automotive and natural resources are building blocks of Canada that improve economic growth.
Science is also fundamental to economic growth,building the future, and has
never been more important.
Every month, staff, researchers, physicians, learners and teams across Unity Health Toronto celebrate important honours, achievements and awards. Congratulations to all who’ve been recognized in May! unityhealth.to/2025/05/may-2…
Reminder that @gliomaregistry’s next webinar on new and emerging treatment strategies for IDH-mutant gliomas is a little over 2 weeks away! This will feature a presentation and Q&A session with @UCSF neuro-oncologist @JennieWTaylor.
🗓️4/30 at 12p EDT
🔗yale.zoom.us/j/94889839093
The Collaborative Centre for Climate, Health & Sustainable Care at @UofT just released the call for abstracts for its 2025 symposium.
I invite you to submit your work.
More info here:
climatehealth.utoronto.ca/ev…
Global Moyamoya Patient Registry is steadily growing.
We invite ALL patients and caregivers to join and contribute to enhancing this important resource for Moyamoya research. Enroll today! cords.sanfordresearch.org/ac…
For more information visit our website: bit.ly/3DtQoKk